Troglitazone and small low-density lipoprotein in type 2 diabetes

被引：23
|
作者：
Hirano, T [1 ]
Yoshino, G
Kazumi, T
机构：
[1] Showa Univ, Sch Med, Tokyo 142, Japan
[2] Toho Univ, Sch Med, Tokyo, Japan
[3] Ilyogo Rehabil Ctr Hosp, Tokyo, Japan
来源：
ANNALS OF INTERNAL MEDICINE | 1998年 / 129卷 / 02期
关键词：
D O I：
10.7326/0003-4819-129-2-199807150-00030
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：162 / 163
页数：2
相关论文
共 50 条
  • [31] Effect of Helicobacter pylori Eradication on Low-Density Lipoprotein Cholesterol in Patients With Type 2 Diabetes
    Alsalman, Omar
    Shady, Ahmed
    Yerragorla, Priyanka
    Al-juboori, Mohammed
    Boktor, Hala
    Bustos, Aulio
    Alchalabi, Marwah
    Harley, Jennifer
    Bergasa, Nora
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S703 - S704
  • [32] Progressive changes in low-density lipoprotein subclasses precede type 2 diabetes in rhesus monkeys
    Ding, SY
    Tigno, XT
    Hansen, BC
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : E85 - E85
  • [33] Higher levels of small dense low-density lipoprotein (LDL) are associated with cardiac autonomic neuropathy in patients with Type 2 diabetes
    Jang, E. -H.
    Park, Y. -M.
    Hur, J.
    Kim, M. -K.
    Ko, S. -H.
    Baek, K. -H.
    Song, K. -H.
    Lee, K. -W.
    Kwon, H. -S.
    DIABETIC MEDICINE, 2013, 30 (06) : 694 - 701
  • [34] Management of Hypertension and High Low-Density Lipoprotein in Pediatric Type 1 Diabetes
    Katz, Michelle L.
    Guo, Zijing
    Laffel, Lori M.
    JOURNAL OF PEDIATRICS, 2018, 197 : 140 - +
  • [35] Pro-apoptotic low-density lipoprotein subfractions in type II diabetes
    Yang, Chao-Yuh
    Chen, Hsin-Hung
    Huang, Max T.
    Raya, Joe L.
    Yang, Jun-Hai
    Chen, Chu-Huang
    Gaubatz, John W.
    Pownall, Henry J.
    Taylor, Addison A.
    Ballantyne, Christie M.
    Jenniskens, Floor A.
    Smith, Charles V.
    ATHEROSCLEROSIS, 2007, 193 (02) : 283 - 291
  • [36] Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin
    Hayashi, Toshiyuki
    Fukui, Tomoyasu
    Nakanishi, Noriko
    Yamamoto, Saki
    Tomoyasu, Masako
    Osamura, Anna
    Ohara, Makoto
    Yamamoto, Takeshi
    Ito, Yasuki
    Hirano, Tsutomu
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [37] Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin
    Toshiyuki Hayashi
    Tomoyasu Fukui
    Noriko Nakanishi
    Saki Yamamoto
    Masako Tomoyasu
    Anna Osamura
    Makoto Ohara
    Takeshi Yamamoto
    Yasuki Ito
    Tsutomu Hirano
    Cardiovascular Diabetology, 16
  • [38] Impact of fluvastatin slow-release on low-density lipoprotein subfractions in patients with type 2 diabetes:: Baseline low-density lipoprotein profile determines specific mode of action
    Winkler, K
    Hoffmann, MM
    Friedrich, I
    Gläser, R
    Abletshauser, C
    Baumstark, MW
    Wieland, H
    März, W
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 221A - 221A
  • [39] VERY LOW-DENSITY LIPOPROTEIN AND LOW-DENSITY LIPOPROTEIN METABOLISM - OVERVIEW
    STEINBERG, D
    JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, 1979, 56 (02) : A189 - A189
  • [40] Comparison of existing methods of low-density lipoprotein cholesterol estimation in patients with type 2 diabetes mellitus
    Sng, Gerald Gui Ren
    Khoo, You Liang
    Yeo, Khung Keong
    Loh, Wann Jia
    Aw, Tar Choon
    Khoo, Joan Joo Ching
    Lee, Lynette Mei Yi
    Tan, Gilbert Choon Seng
    Tan, Hong Chang
    Bee, Yong Mong
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2023, 52 (06) : 280 - 288
12345